Clinical trial
3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PE
NCT00365950 · British Thoracic Society, Other · Completed
Key facts
| NCT number | NCT00365950 |
|---|---|
| Title | 3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PE |
| Official title | Clinical Trial of Two Durations of Warfarin Therapy in the Treatment of Deep Vein Thrombosis and/or Pulmonary Embolism |
| Lead sponsor | British Thoracic Society, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Deep Vein Thrombosis, Pulmonary Embolism, Deep Vein Thrombosis With Pulmonary Embolism |
| Intervention type | Drug |
| Interventions | Duration of anticoagulation, Warfarin duration |
| Enrollment | 2,400 |
| Start date | Sep 1, 1999 |
| Completion | Dec 1, 2003 |
| First posted | Aug 18, 2006 |
| Last update posted | Aug 18, 2006 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: